[Federal Register Volume 77, Number 122 (Monday, June 25, 2012)]
[Notices]
[Page 37911]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-15393]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-N-0001]


Oncologic Drugs Advisory Committee; Amendment of Notice

AGENCY:  Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing an amendment 
to the notice of meeting of the Oncologic Drugs Advisory Committee. 
This meeting was announced in the Federal Register of May 31, 2012 (77 
FR 32125-32126). The amendment is being made to reflect a change in the 
Date and Time, and Procedure portions of the document. The Date and 
Time of the meeting will change to July 24, 2012, from 8 a.m. to 6 p.m. 
The Procedure portion of the document has changed to reflect an updated 
public participation time of 10:30 a.m. to 11 a.m., and 4:30 p.m. to 5 
p.m. There are no other changes.

FOR FURTHER INFORMATION CONTACT: Caleb Briggs, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301-
796-9001, FAX: 301-847-8533, [email protected], or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), and follow the prompts to the desired center or 
product area. Please call the Information Line for up-to-date 
information on this meeting.

SUPPLEMENTARY INFORMATION:  In the Federal Register of May 31, 2012, 
FDA announced that a meeting of the Oncologic Drugs Advisory Committee 
would be held on July 24, 2012. On page 32125, in the third column, the 
Date and Time portion of the document is changed to read as follows:
    Date and Time: The meeting will be held on July 24, 2012 from 8 
a.m. to 6 p.m.
    On page 32126, in the first column, the third sentence in the 
Procedure portion of the document is changed to read as follows:
    Procedure: Oral presentations from the public will be scheduled 
between approximately 10:30 a.m. to 11 a.m., and 4:30 p.m. to 5 p.m.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

    Dated: June 20, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2012-15393 Filed 6-22-12; 8:45 am]
BILLING CODE 4160-01-P